Insider trades
Frank McCormick, Director of BridgeBio Pharma BBIO, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $13.3M. The latest trade was on 06/22.
Frank McCormick
Director
- Company
- BridgeBio Pharma BBIO
- First filing
- 23/02/23
- Trades
- 23 trades
- Buys / sales
- 0 / 9
- 12-month net buying
- −$13.3M
- Last trade
- 06/22
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
BBIO | Open-market sale10b5-1 plan | 25/10/29 | 25/10/31 | 198,359 sh5 trades | $66.58avg. | $13,207,208.36 | −22.6% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 25/10/27 | 25/10/29 | 1,641 sh | $65.00 | $106,665 | −0.2% |
BridgeBio PharmaBBIO | Open-market sale | 25/09/05 | 25/09/08 | 74,000 sh | $53.16 | $3,933,840 | −47.1% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 25/06/24 | 25/06/26 | 100,000 sh | $44.23 | $4,423,000 | −10.2% |
BridgeBio PharmaBBIO | Open-market sale10b5-1 plan | 23/12/26 | 23/12/28 | 100,000 sh | $42.06 | $4,206,000 | −13.7% |